Does RAVULIZUMAB-CWVZ Cause Red cell distribution width increased? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Red cell distribution width increased have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.1% of all adverse event reports for RAVULIZUMAB-CWVZ.
14
Reports of Red cell distribution width increased with RAVULIZUMAB-CWVZ
0.1%
of all RAVULIZUMAB-CWVZ reports
2
Deaths
5
Hospitalizations
How Dangerous Is Red cell distribution width increased From RAVULIZUMAB-CWVZ?
Of the 14 reports, 2 (14.3%) resulted in death, 5 (35.7%) required hospitalization.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Red cell distribution width increased Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST